CRISPR Therapeutics AG (CRSP)
56.25
-0.51
(-0.90%)
USD |
NASDAQ |
Apr 16, 09:39
CRISPR Therapeutics Total Assets (Quarterly) : 2.265B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Novartis AG | 115.57B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
| Basilea Pharmaceutica AG | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 343.43M |
| Shareholders Equity (Quarterly) | 1.922B |
| Debt to Equity Ratio | 0.1076 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | 0.08% |